SCHEMBL27263264

SCHEMBL27263264

Clc1ccc(Br)c(CCOC2CCCCO2)c1

nearest known ligand 0.46

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
KDM4C Q9H3R0 1/20 0.46
L3MBTL1 Q9Y468 1/20 0.43
NPC1 O15118 1/20 0.42
RAB9A P51151 1/20 0.42
MEN1 O00255 1/20 0.39
KMT2A Q03164 1/20 0.39
NOS3 P29474 1/20 0.36
NOS1 P29475 1/20 0.36
NOS2 P35228 1/20 0.36
P2RX3 P56373 10/20 0.35
KCNA5 P22460 1/20 0.33
SCN5A Q14524 1/20 0.33
HTR2C P28335 2/20 0.33
SLC6A4 P31645 2/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31394558 0.87 NOS3 (0.38) KDM4CL3MBTL1NPC1RAB9AMEN1
SCHEMBL875673 0.85 L3MBTL1 (0.57) KDM4CL3MBTL1NPC1RAB9AMEN1
SCHEMBL31588436 0.84 KDM4C (0.44) KDM4CL3MBTL1NPC1RAB9AMEN1
SCHEMBL2317607 0.84 KDM4C (0.48) KDM4CL3MBTL1NPC1RAB9AMEN1
SCHEMBL6400712 0.82 NPC1 (0.59) KDM4CL3MBTL1NPC1RAB9AMEN1
SCHEMBL772902 0.81 KDM4C (0.53) KDM4CL3MBTL1NPC1RAB9AMEN1
SCHEMBL24252402 0.80 KDM4C (0.46) KDM4CL3MBTL1NPC1RAB9AMEN1
SCHEMBL9570948 0.78 KDM4C (0.49) KDM4CL3MBTL1NPC1RAB9AMEN1
SCHEMBL31588961 0.77 KDM4E (0.41) L3MBTL1KMT2ANOS3NOS1NOS2
SCHEMBL12963637 0.77 NPC1 (0.47) KDM4CL3MBTL1NPC1RAB9AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-120035598-A Method for preparing PRMT5 inhibitor 普莱鲁德疗法股份有限公司 2025-05-23 CN disclosed
EP-4540261-A1 PROCESSES FOR MAKING PRMT5 INHIBITORS Prelude Therapeutics Incorporated (US) 2025-04-23 EP disclosed
WO-2023245037-A1 PROCESSES FOR MAKING PRMT5 INHIBITORS PRELUDE THERAPEUTICS INCORPORATED (US) 2023-12-21 WO disclosed
WO-2023245037-A1 PROCESSES FOR MAKING PRMT5 INHIBITORS PRELUDE THERAPEUTICS INCORPORATED (US) 2023-12-21 WO disclosed